|5-day-on & 2-day-off treatment
Jan 26, 2005
Dear Doctor Conway
Due to Lipoatrophy, I was just informed by doctor to do above-mentioned treatment. For your information, I have been on drugs combination of COMBIVIR AND SUSTIVA for almost 7.5 years. The viral load and CD4 have been <50 and about 450 during this period. Prior to take drugs, viral load and CD4 were about 28,000 and 298, respectively. Please advise.
Thank you Charle
| Response from Dr. Conway
The concept of five days on and two days off (so called "FOTO") therapy is one that was meant to limit the cost of therapy as well as its short and long term toxicity while not sacrificing efficacy. Initial data suggest that it is promising, but needs to be studied within a controlled clinical trial, as it is not known whether it will lead to premature loss of efficacy as compared to continuous HAART. As long as you understand the potential risks and benefits, this could be a very good clinical trial for you to enter.
I would, however, caution you that it is not clear whether the FOTO approach would be any better than continuous HAART in reversing established lipoatrophy.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Flu Symptoms After Insertive Oral Sex Worried I Have HIV
- Groin Pain After Anal Sex Top Sign Of HIV AIDS
- Oral Ulcers After Touching Precum Sign Of HIV AIDS
- Tingling Lips After Touching Vagina Worried I Have HIV
- Can You Get Genital Warts From Sharing Razors Or Drinks?
- Does Doxycycline Cure Chlamydia In One Day?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.